• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·China·Healthcare·300452.SZ
Share

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. Stocks

CN¥ 12.87Last Updated 22.05.2026

Issuer Rating

5/7
Performance

Favourable

Risk

Limited

Recommendation

Hold

Market Cap

CN¥ 457.88M

CN¥ 12.87
Key Takeaways

Risk factor

Fair trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong margins and returns

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. manufactures and sells pharmaceutical excipients and professional medicines in China. The company provides cellulose, starch, povidone, stearic acid, coating powder, resin, food additive, and other products. It also exports its products to Europe, the United States, Southeast Asia, and internationally. Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. is based in Huainan, China.

Company Valuation

Slightly undervalued
5/7

From both historical and forecast perspectives, the stock is moderately underpriced compared to similar stocks. In particular, the stock is reasonably priced on P/E, of f

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Slightly negative
3/7

The average target price of 300452.SZ is 15 and suggests 17% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

25.05.2026 20:49

Delivery Hero shares soared 12%. Will Uber raise rates to buy out a competitor?

25.05.2026 19:02

'Drop another Tower of Babel': Pope urged to 'disarm' AI

25.05.2026 17:59

Italian stocks hit a record for the first time in 26 years. Which securities are leading the growth?

25.05.2026 17:13

Surprise for the market: Huawei claims a breakthrough in chip design. How does this threaten Nvidia

25.05.2026 16:11

Analyst names two mid-cap stocks that will benefit from decarbonization and AI development

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026